We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (383)
- Scheduling (national classification system) (164)
- Safety monitoring and information (26)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Medicinal cannabis hub (6)
- Clinical trials (5)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
758 result(s) found, displaying 176 to 200
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsCommunique from the 3rd meeting of the Women's Health Products Working Group (WHPWG), 27 March 2023
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsMeeting statement from the Advisory Committee on Medical Devices (ACMD), 13 April 2023.
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Corporate reportsThe Access Consortium is offering joint pipeline meetings to pharmaceutical and biotechnology companies.
-
Meeting statementsMeeting statement from meeting 10 of the MDCWG.
-
Scheduling decisions (final)Public notice of final decision to amend (or not amend) the current Poisons Standard - ACMS #40, ACCS #34, Joint ACMS-ACCS #32
-
Scheduling submissionsPublic submissions on interim decisions for scheduling matters referred to the ACMS #40, ACCS #35 and Joint ACMS-ACCS #32 meetings held in November 2022
-
Scheduling decisions (final)On 3 May 2023, the TGA announced the final decision to amend the scheduling of paracetamol in the Poisons Standard.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 3 November 2022
-
Meeting statementsMeeting statement from the Advisory Committee on Medical Devices (ACMD), 9 February 2023.
-
Corporate reportsThe Action Plan will further improve Australia’s medical device regulatory system, placing patient safety first.
-
Corporate reportsThe report cards show the progress made by the TGA in the 3 strategies that make up the Action Plan for Medical Devices.
-
Scheduling submissionsPublic submissions on interim decisions for scheduling matters referred to ACMS, ACCS and Joint meetings held in June 2022
-
Scheduling submissionsPublic submissions on interim decisions for scheduling matters referred to ACMS, ACCS and Joint meetings held in November 2022
-
Scheduling decisions (final)Public notice of final decisions to amend (or not amend) the Poisons Standard - ACMS, June 2022
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 3 March 2023
-
Meeting statementsMeeting statement from meeting 9 of the MDCWG.
-
Meeting statementsMeeting statement from the Advisory Committee on Medical Devices (ACMD), December 2022.
-
Scheduling decisions (final)Public notice of final decisions to amend (or not amend) the Poisons Standard - ACMS, ACCS and joint ACMS-ACCS, June 2022
-
Meeting statementsCommunique from the 2nd meeting of the Women's Health Products Working Group (WHPWG), 20 October 2022